Overview
No overview information available.
Indication
No indication information available.
Associated Conditions
No associated conditions information available.
Research Report
Ibutamoren (MK-677): A Comprehensive Pharmacological and Clinical Monograph
Section 1: Compound Profile and Physicochemical Characteristics
Ibutamoren is an orally bioavailable, small molecule, non-peptide growth hormone secretagogue (GHS) that has been the subject of extensive investigation for its potential therapeutic applications.[1] As an investigational compound, it has been evaluated in numerous clinical trials, reaching a maximum phase of II for at least one indication.[1] This section provides a definitive chemical and physical profile of Ibutamoren, establishing the fundamental properties that govern its pharmacological behavior.
1.1. Nomenclature and Chemical Identifiers
To ensure unambiguous identification across chemical, pharmacological, and regulatory databases, Ibutamoren is cataloged under a variety of names and codes. The distinction between its free base and salt forms is critical for the accurate interpretation of scientific literature and experimental reproducibility.
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|---|---|---|---|---|
2025/08/19 | Not Applicable | Not yet recruiting | |||
2025/04/29 | Phase 3 | Recruiting | |||
2023/04/03 | Phase 2 | ENROLLING_BY_INVITATION | |||
2022/05/06 | Phase 2 | Completed | |||
2022/02/22 | Phase 2 | Completed | |||
2021/03/19 | Phase 2 | Active, not recruiting | |||
2020/11/04 | Phase 2 | Completed | |||
2011/04/28 | Phase 2 | Withdrawn | |||
2006/11/02 | Not Applicable | Completed | |||
2005/08/09 | Phase 2 | Terminated |
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
|---|---|---|---|---|---|
| No FDA approvals found for this drug. | |||||
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
| No EMA approvals found for this drug. | |||
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No HSA approvals found for this drug. | |||||
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| No NMPA approvals found for this drug. | |||||
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| No PPB approvals found for this drug. | |||||
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
|---|---|---|---|---|---|
| No TGA approvals found for this drug. | |||||
Health Canada Drug Approvals
Approved Product | Company | DIN | Dosage Form | Strength | Market Date |
|---|---|---|---|---|---|
| No Health Canada approvals found for this drug. | |||||
CIMA AEMPS Drug Approvals
Approved Product | Company | Registration Number | Pharmaceutical Form | Prescription Type | Status |
|---|---|---|---|---|---|
| No CIMA AEMPS (Spain) approvals found for this drug. | |||||
Philippines FDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Philippines FDA approvals found for this drug. | |||||
Saudi SFDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Saudi SFDA approvals found for this drug. | |||||
Malaysia NPRA Drug Approvals
Approved Product | Company | Registration Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Malaysia NPRA approvals found for this drug. | |||||
UK EMC Drug Information
Medicine Name | MA Holder | MA Number | Pharmaceutical Form | Active Ingredient | Authorization Date |
|---|---|---|---|---|---|
| No UK EMC drug information found for this drug. | |||||
Help Us Improve
Your feedback helps us provide better drug information and insights.